Zindotrine

This classification denotes a bronchodilator and beta-adrenergic agonist with the molecular formula C11H15N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VQM3328PO0, chemically known as 1,2,4-triazolo(4,3-b)pyridazine, 8-methyl-6-(1-piperidinyl)- but generally known as zindotrine, which bears US NIH Compound Identifier 41856. European Medicines Agency schedules Zindotrine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00162MIG. The term ZINDOTRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). ZINDOTRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule zindotrine under HS 29333999 and SITC 51574. As of Q4 2014, ZINDOTRINE remains the US FDA Preferred Term for this commodity. Zindotrine bears US NLM identifiers UMLS ID C0078807 and NCI Concept Code C66695. SMILES: CC1=CC(=NN2C1=NN=C2)N3CCCCC3.